Abstract: Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-conedystrophy,polydactyly,hypogonadisminmales,andrenalabnormalities.ThecausativegeneshavebeenidentifiedasBBS1-14. IntheWesterncountries,theprevalenceofthisdiseaserangesfrom1/13,500to1/160,000,whileonlyafewJapanesepatientshave been reported in the English-language literature. The incidence of renal dysfunction or anomalies in previous reports varies considerably ranging from ∼20%touniversaloccurrence.WeherereportthattwoJapanesepatientswhohadBBSwithnormalBUNandcreatinine levelshadelevatedlevelsofcystatinC,asensitivemarkerofglomerularfiltrationrate.Aurinealbuminlevelincreasedonlyintheelder patient.Thus,cystatinCmaybeusefulfordetectingrenalabnormalitiesinpatientswithanapparentnormalrenalfunction.Becausethis disease is diagnosed by accumulation of symptoms, such a sensitive marker might help early diagnosis of BBS.
Introduction
Bardet-Biedl syndrome (BBS) is an autosomal recessive disorder characterized by central obesity, mental impairment, rod-cone dystrophy, polydactyly, hypogonadism in males, and renal abnormalities.
1,2
The causative genes have been identified as BBS1-14genesthatencodeproteinspossiblylinked tociliafunction,butmorethan20%ofpatientshave no mutations found. 3 The diagnosis is made only by the clinical phenotype with the presence of at least three major symptoms,however,itisoftendifficult partly because of age-dependent development of some symptoms. In the Western countries, the prevalence of this disease ranges from 1/13,500 to 1/160,000. 3 Bycontrast,onlyafewJapanesepatientshavebeen reported in the English-language literature.
4-6
Renal fibrosis is one of the most devastating symptoms, ultimately leading to chronic renal failure requiring hemodialysis. 7 The incidence of renal dysfunction or anomalies in previous reports varies considerably ranging from ∼20% to universal occurrence. 2, 7 An early detection of such abnormalities may be important for patients and guardians to prepare them. It may also be useful for prompt correct diagnosis of BBS, since the diagnosis of this disease is based on the accumulation of major symptoms as described above. We nowreportthattwoJapanesepatientswithBBShad normalBUNandcreatininelevelbutelevatedlevels of cystatin C, a sensitive marker of glomerular filtrationrate(GFR).
patients A20-year-oldman(patient1)hadmentalretardation (minimental state examination 23; normal . 24), rod-conedystrophy,centralobesity(height158cm, weight 63 kg, and BMI 25.2) and hypogonadism since the age of 5 years. His waist circumference was83.5cm.Hisbloodpressurewas131/85mmHg, andhisheartratewas61beats/min.Hehadnormal heartsoundswithclearbreathsounds.A 16-year-old boy(patient2),theyoungerbrotherofpatient1,had polydactyly in addition to the symptoms described above(height165cm,weight93kg,andBMI34.2). His waist circumference was 107 cm. His blood pressure was 128/61 mmHg, and his heart rate was 77beats/min.Hehadnormalheartsoundswithclear breath sounds. Their non-consanguineous parents were apparently healthy. The symptoms of patients andprobableautosomalrecessive inheritance fulfilled the diagnostic criteria for BBS5. After obtaining informedconsent,aDNAchipstudywasperformed atAsperBiotechLtd.(Tartu,Estonia).TheDNAchip (version 5) covered 305 mutations from 14 genes causativeforBBSandrelateddiseases(BBS1,BBS2, BBS3, BBS4, BBS5, BBS6, BBS7, BBS8, BBS9, BBS10, BBS12, PHF6,ALMS1, and GNAS1), but identified no pathological alterations. Nevertheless, becauseaboutonefifthofpatientswithclinicallydefiniteBBShavenoidentifiablemutationsasdescribed above and because the chip covered only mutations previously reported to be pathogenic, these results could not rule out the possibility of a diagnosis of BBS in our family.
Tests for Renal Morphology and Function, and Other Laboratory Tests
To detect morphological renal abnormalities, the patients underwent abdominal CT scans and abdominalsonography,withnoapparent anomalies. Blood and urine tests routinely performed in Japan failed to identify any obvious abnormalities ( Table 1 , upper rows). Other laboratory data of the elder and younger patients included normal bloodsugar levels(78mg/dland81mg/dl,respectively), normaltotalcholesterollevels(144mg/dl and131mg/dl, normal120-220mg/dl),unelevated triglyceridelevels(28mg/dland72mg/dl,normal 30-150mg/dl), negativeserumCRP,andnegative urineoccultbloodorglucose.Creatininewasmeasured by an enzymatic method. Serum cystatin C andurinealbuminwerethenexamined. CystatinC was measured by a colloidal gold agglutination method. The results showed elevated cystatin C concentrations in both patients and microalbuminuria in the elder patient (Table1,lowerrows). Cystatin C levels of the age-and sex-matched controlswerealsoexamined,theresultofwhichshowed 0.86mg/Lforaneldercontroland0.91mg/Lfora younger control.
Discussion
We describe abnormal levels of serum cystatin C in two patients with BBS (Table 1 ). Cystatin C is a plasma protein with a molecular weight of 13.4 kDa and belongs to the cysteine protease inhibitors. 8 It is constantly synthesized in all types of cells, excreted into plasma, and filtered completely by the glomeruli. Consequently, increasing serum levels of this marker indicate decreasing GFR. MeasurementofcystatinCmoresensitively detectsmildGFR abnormalitiesthanthatofcreatinine, a more common but less sensitive marker of GFR, 8 probably because the lower molecular weightofcreatinine(113Da) facilitatesitseasier filtration in the glomeruli. In addition to the sensitivity, cystatin C is a more reliable marker than creatinine for detection of chronic renal disease, since creatinine levels are affected by many extrarenal patient-related factors such as muscle mass and consumption of cooked meat that is a source of creatinine.
8 Ourpatientshadonlymildincreasesin cystatinC.Nevertheless,becausecystatinC levels age-dependently increase with decreasing GFR, thevaluesofouryoungpatientsseemsufficiently high for their ages. Aurinealbuminlevelincreasedonlyintheelder patient. Patients with BBS occasionally manifest proteinuria, 7 suggesting that patients had not only decreased GFR but also increased protein leakage. Urine albumin is used to detect early phases of diabetic or hypertensive nephropathy.
9 Because neitherofourpatientsshowedapparent proteinuria, the elder patient may be in an early phase of protein leakage. In diabetes mellitus, timely treatment with an angiotensin-converting enzyme inhibitor, independently of rise in arterial blood pressure, is considered if improvement of glycaemic control and moderate decrease of dietary protein intake for 6-12 months have failed to reduce the albumin excretion rate.
9
Screening programs for microalbuminuria and early intervention can substantially modify the natural history of diabetic renal involvement and disease and possibly reduce the incidence of end-stage renal failure. 9 In BBS, although such intervention has not been tested yet, wemayconsidersimilarprotectivemethodsforrenal dysfunction.
In conclusion, patients who have BBS with apparently normal kidney functions may have abnormal levels of cystatin C, facilitating an early detection of kidney dysfunctions that might be helpful for prompt correct diagnosis of BBS. However, because our study is based on the results of the small number of patients, conclusion must await further studies. 
